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Veno-venous extracorporeal membrane oxygenation (VV ECMO) has been used for refractory 
respiratory failure.  We describe the indications, technical aspects, and outcomes of placing VV 
ECMO in adults using a dual-lumen, single-cannula catheter. 
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Introduction 
Veno-venous extracorporeal membrane oxygenation (VV ECMO) is used for refractory 
respiratory failure.  Previously, we described our technique of percutaneous placement of veno-
arterial (VA) ECMO cannulas.1 We now describe the percutaneous placement of a cannula for 
VV ECMO support, including indications, patient assessment, preparation for cannulation and 
the technical aspects of the procedure using a double lumen bi-caval cannula (Avalon, Maquet, 
Rastatt, Germany).  
Indications  
VV ECMO is reserved for patients with compromise of their ventilation or oxygenation 
status that is refractory to optimum mechanical ventilation and medical therapy.2-4 In VV 
ECMO, deoxygenated blood is drained from the venous system, and sent through an external 
circuit which contains a gas-permeable membrane that removes carbon dioxide and an 
oxygenator that oxygenates the blood.  Thereafter the blood is returned to the venous system, 
whereas in VA ECMO the oxygenated blood is returned to the arterial system.1   Distribution of 
the oxygenated blood to the patient in VV ECMO requires viability of the patient’s own 
circulatory system and therefore VV ECMO depends on the patient having normal cardiac 
function to maintain adequate perfusion. 4 Thus, the primary indication of VV ECMO is severe 
acute ventilatory and/or oxygenation failure that the patient is unlikely to survive with 
conventional mechanical ventilation but is potentially reversible and is not associated with 
cardiac failure.2-4  
Common conditions of reversible respiratory failure for which VV ECMO is a potential 
treatment option include adult respiratory distress syndrome (ARDS) due to aspiration, 
viral/bacterial/atypical pneumonia, barotrauma, and acute on chronic interstitial pneumonitis.4    
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The patients who are not candidates for VV ECMO are those patients who have advanced and/or 
irreversible disease processes, such as overwhelming sepsis, non-pulmonary multi-organ failure, 
irreversible neurological injury, terminal illness or other life limiting disease.  Additionally, 
patients with ventilator dependent respiratory failure or chronic respiratory failure that lack the 
potential to be bridged to lung transplantation are not candidates for VV ECMO.  Finally, 
patients with cardiac dysfunction should receive VA ECMO support. 
Pre-procedural assessment 
Typical candidates are hypercapnic, hypoxic and unresponsive to optimal medical 
management, including low-tidal volumes, bronchodilator treatment, administration of 
epoprostenol, paralysis, and appropriate diuresis.2  It is important to establish the acute nature of 
the respiratory failure, ruling out cardiac or other non-pulmonary organ failure, and confirming a 
failure to improve with ventilator management.  If it appears VV ECMO is clinically indicated 
and the patient would benefit from the therapy, the next step is to identify any patient factors that 
may prevent placement of the VV ECMO cannula. 
The right internal jugular vein should be evaluated with ultrasound to identify intrinsic or 
acquired vascular pathologies including deep vein thrombosis, stenosis or previous stent 
placements that may preclude cannula placement.  The placement of cannulas may be technically 
difficult in morbidly obese patients.  Additional information such as coagulopathies or any 
contraindications to anticoagulation should be noted.  Echocardiography should be performed 
before the procedure to rule out cardiac dysfunction or structural abnormalities such as a patent 
foramen ovale or tricuspid regurgitation. 5   The presence of those structural abnormalities may 
cause inadequate mixing of ECMO inflow and outflow.  Additionally, VV ECMO placement in a 
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patient with cardiac failure of either side can result in cardiac over-distension and worsening 
pulmonary edema.  
The protocol at our institution for patients who meet criteria for VV ECMO but who are 
not candidates for this system secondary to limitations of venous access, cardiac dysfunction or a 
structural abnormality is to place VA ECMO.  
The local internal review board approved this presentation.  
Traditional VV ECMO cannulation 
Prior to the advent of the Avalon cannula, placement of VV ECMO support required 
multiple cannulation sites.  The traditional VV ECMO system involved bilateral groin 
cannulations with one long venous cannula extending into the right atrium serving as inflow of 
oxygenated blood to the patient and one short venous cannula ending in the inferior vena cava 
(IVC) serving as outflow of the unoxygenated blood (Figure 1A).  A second variation of the pre-
Avalon VV ECMO system consisted of an outflow cannula in the groin ending in the IVC and a 
inflow cannula in the right atrium placed from the upper extremity (Figure 1B).  These VV 
ECMO systems may result in ineffective oxygenation via ECMO due to the proximity of the 
inflow and outflow cannulas: the outflow cannula could be drawn back into the ECMO circuit 
without going into the patient’s circulatory system.  Another potential issue of these double 
cannulation systems was the potential for low ECMO flow related to a relatively easily 
collapsible IVC due to suction effect from the outflow cannula, which often observed in low 
intravascular volume status. 
Avalon double lumen bi-caval cannula 
In our practice, we use a double lumen bi-caval cannula (Avalon cannula) for VV 
ECMO.  This Avalon cannula is a rigid straight cannula that was designed to be inserted from the 
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right internal jugular vein into the IVC.  Due to the rigidity of the cannula, other upper extremity 
cannulation such as subclavian or left internal jugular vein access is not recommended.  The 
Avalon catheter has 3 ports referred to as the proximal, middle and distal ports.  The distal port 
located at the tip of the Avalon cannula should be placed just below the atrial-IVC junction.  
Once the distal port is positioned inside the proximal portion of the IVC, the proximal port of the 
cannula should be in the SVC.  These proximal and distal ports drain unoxygenated blood from 
the upper and lower body, respectively.  The middle port of the Avalon catheter should rest in 
the right atrium and ideally face towards the tricuspid valve.  Oxygenated blood from ECMO 
circuit is delivered to this middle port.  Then the oxygenated blood is circulated to the pulmonary 
vasculature followed by the systemic circulation by native cardiac function.6,7  The Avalon 
cannula has specially designed to minimize inflow-outflow reperfusion and shunting of 
oxygenated blood. 
The additional advantage of the dual-lumen design of the Avalon catheter is that it does 
not require femoral cannulation.  Femoral cannulation hinders the ability to use prone 
positioning, which is a common secondary intervention performed in VV ECMO patients to 
improve oxygenation and lung recruitment.  Avoiding a femoral cannulation also allows patients 
to sit in bed or even ambulate while on VV ECMO support.4  
Cannulation technique 
Prior to initiation of the procedure, a central venous line and an arterial line should be in 
place for proper monitoring of hemodynamics and access available for infusion of vasopressors 
and volume as needed throughout the procedure.  If the right internal jugular vein is already used 
for central line access, an alternative central line should be obtained since the Avalon cannula is 
going to be placed in the right internal jugular vein.  Echocardiography should be available at the 
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bedside.  If adequate visualization of the cardiac structures was not obtained by transthoracic 
echocardiography, transesophageal echocardiography should be used and the echo probe should 
be in position prior to skin prep for ECMO cannulation. 
Percutaneous placement of VV ECMO cannulas can be performed in a variety of hospital 
settings including an emergency room, a cardiac cauterization laboratory, an intensive care unit 
or an operating room; however use of fluoroscopy is strongly recommended to ensure proper 
positioning of the wires and the cannula.  We prefer to use a percutaneous approach to place the 
cannula as this minimizes bleeding from the cannulation site.  The procedure is preferentially 
performed in the intensive care unit with fluoroscopy with trained personnel, support staff and 
the necessary equipment being readily available.  Prior to the procedure, the patient needs to be 
sedated adequately with an airway properly secured. 
Two operators should be available to control the wires and cannulas.  The patient is 
prepped and draped sterilely and a single dose of intravenous antibiotics is administered.  We 
routinely prep both groins for a possible conversion to VA ECMO in case we fail to obtain right 
internal jugular vein access.  
Percutaneous puncture of the right internal jugular vein is performed under ultrasound 
guidance.  The puncture site should be some distance from the clavicle.  Otherwise, it is difficult 
to obtain adequate exposure upon decannulation or if the vessel needs to be repaired.  
Fluoroscopy is then used to pass a flexible j-tip guidewire from the internal jugular vein into the 
IVC.  The tip of the guide wire should be placed beyond renal veins to avoid dislodgment or 
migration of the wire (Figure 2A).  If the guidewire is not deep enough, the cannula may migrate 
to the right ventricle or to the hepatic vein.  The Avalon insertion kit (Avalon elite vascular 
access kit, Maquet, Rastatt, Germany) includes one flexible j-tip 0.038 inch x 210 cm guidewire 
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and serial dilators (10 Fr, 12 Fr, 16 Fr, 20 Fr and 24 Fr).  The wire in the Avalon cannulation kit 
may be too flexible to manipulate the wire to the appropriate position.  Occasionally, the 
presence of a large Eustachian valve at the caval-atrial junction may cause the wire to travel into 
the right ventricle instead of the IVC.  In this case, a stiffer J-tip wire (0.038 inch x 210 cm, 
Edwards Lifescience LLC, Irvine, CA) or alternative stiffer wires including the Amplatz Stiff 
Wire TM or Amplatz Super Stiff Wire TM (Boston Scientific, Washington, DC) may be substituted 
for the flexible wire in the Avalon kit.  Using the Seldinger technique, the access site is 
progressively enlarged with serial dilators placed over the (Figure 2B).  Thick skin or fascia may 
be present which requires forceful manipulation of the dilators until the access site is sizeable 
enough to accommodate placement of the cannula.   During the vigorous dilatation of the soft 
tissue, the wire may kink or dislodge.  Confirmation of the position of the wire is necessary with 
fluoroscopy each time the dilator is used.  The access site should be held with a finger to 
minimize the blood loss whenever dilators are exchanged. 
Cannulas are selected preoperatively based on manufacture pressure flow curves and the 
optimal flow calculated from a formula based on body surface area (BSA) x 2.2.  We use this 
formula to provide optimal cardiac index.  Usually, maximum flow is limited to 3 L/min with use 
of a 23Fr cannula, 4.5 L/min with a 27Fr cannula, and greater than 6.5 L/min with 31Fr Avalon 
cannula.  Although ECMO cannulas have the ability to run above the recommended flow, doing 
so may cause hemolysis; thus, in general, our policy is to utilize the largest cannula feasible. 
Systemic anticoagulation is required to prevent forming thrombus in the ECMO circuit.  
Therefore, after the tract is dilated, a 5000 unit intravenous bolus of heparin (7500 units for BSA 
>2.2) is administered to prevent thrombosis prior to placement of the Avalon cannula.  An inner 
stylet was placed in the Avalon cannula to facilitate the insertion over the guide wire along the 
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dilated tract.  The tip of the inner stylet should be followed by fluoroscopy to ensure not to kink 
the wire by the sharp tip of the inner stylet.  The inner stylet is partially withdrawn as the cannula 
is inserted into the SVC to avoid injury to the right atrium by the inner stylet.  Fluoroscopy 
should be used to confirm the cannula tip terminates in the IVC (Figure 2C, Figure 3A).  The 
wire and inner stylet are then completely removed and the two ends of the catheter (venous and 
arterial) are clamped.  The ends of the cannula are connected to the ECMO circuit taking care to 
avoid introducing air bubbles into the tubing.  The connection and circuit should be carefully and 
continuously examined for trapped air prior to unclamping, given the potentially catastrophic 
complications that would result both from air emboli to the patient and the no-flow phenomenon 
due to disturbance of the centrifugal pump in the ECMO circuit.  Once both the venous and 
arterial sides of the catheter are connected to the ECMO circuit, all clamps are removed and the 
circuit is started on full flow (approximately 4-5 L/min, BSA x 2.2 L/min). 
At this point a bedside echocardiography is performed to confirm the middle port of the 
catheter is positioned in the right atrium with outflow jetting into the tricuspid valve (Figure 
3B).5   The cannula can be moved manually to position the middle port of the cannula if needed.   
The catheter is secured to the skin with several sutures. 
The entire procedure takes about 30 minutes with minimal blood loss (less than 100cc is 
expected).  However, it is advisable to have two units of packed red blood cells as well as 
vasopressor support readily available.  During the first a few hours of the ECMO, volume 
replacement is often necessary to keep adequate ECMO flow.  The chattering of the ECMO 
tubing may be the first indication of intravascular volume depletion.  
Patient Management on VV ECMO 
 10 
Initial ECMO settings are 100% FiO2 and a sweep of 5 to 6 L/min.  Once the patient is 
placed on ECMO, ventilator settings can be reduced to appropriate ARDSnet settings: tidal 
volume 4-6 cc/kg, ventilator rate of 10 breaths /min, and a PEEP of 8-10 cm H2O to prevent 
barotrauma.  An arterial blood gas should be drawn 20 minutes after initiation of ECMO.  Based 
on the arterial blood gas, the ECMO sweep is adjusted to allow for adequate CO2 clearance.   
Titration of respiratory rate or tidal volume settings on the ventilator is usually not necessary 
since the ECMO can be adjusted to clear CO2.  To minimize oxygen toxicity, the FiO2 of the 
ventilator should be reduced as tolerated followed by reduction of the FiO2 of the ECMO.  The 
oxygenation goal of VV ECMO is a FiO2 of 50% from both the ventilator and the VV ECMO 
circuit.  
Once initial stabilization is achieved and the patient demonstrates improved oxygenation, 
secondary measures to facilitate alveolar improvement and overall oxygenation can be 
implemented.  Bronchoscopy should be performed for pulmonary toilet and sampling of 
bronchial secretions for culture.  The prone positioning bed (Rotaprone bed, KCI, San Antonio, 
TX) can be utilized to facilitate recruitment of the lung.  In our practice, the patients on VV 
ECMO are deeply sedated to avoid the risk of cannula migration, to minimize bleeding from the 
cannula, and to allow for use of the prone positioning bed until recovery of the lung injury.  In 
the younger patient population, sedatives such as ketamine may be necessary in addition to 
midazolam and fentanyl.  These patients with acute respiratory failure could be different from 
the those who  with chronic respiratory failure or patients who are candidates for lung 
transplantation.   can potentially be extubated and ambulate while on the ECMO.  In clinical 
situations involving persistent ARDS, once bacterial infection is excluded, we administer high-
dose corticosteroids per the Meduri protocol.4   
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Anticoagulation using a continuous heparin infusion is started 24 hours after placement 
of the ECMO circuit and monitored using the prothrombin time (PTT), with a therapeutic goal of 
45-55 sec.  In instances of bleeding from the cannulation or other sites, the anticoagulation can 
be held for up to 48 hours.  
The patient is continuously evaluated for weaning from the VV ECMO system based on 
respiratory function parameters including compliance and the daily chest x-ray findings.  Once a 
FiO2 requirement of less than 50% is achieved on the ECMO circuit and the ventilator and the 
chest x-ray demonstrates improvement, tidal volume and respiratory setting is gradually 
increased on the ventilator and the sweep of the ECMO is reduced.  Once a minimum sweep of 
less than 2 L/min is achieved, the ECMO can be removed.  In instances where airway pressure 
rises with ventilator manipulation, the patient is not considered stable enough for decannulation 
and ECMO support should be continued until pulmonary function fully recovers.  Open 
decannulation and primary repair of the vessel is recommended for decannulation of ECMO, as 
complications including unexpected bleeding are more readily addressed. 
Our experience of VV ECMO 
Institutional review board approval was obtained to present our 5-year institutional 
experience.  Between July 2010 and June 2015, a total of 45 VV ECMOs were performed for 
acute respiratory failure with severe ARDS secondary to viral pneumonia (16), bacterial, fungal 
or PCP pneumonia (6) aspiration (10), interstitial pneumonitis (5), pancreatitis related hypoxia 
(3), postcardiotomy respiratory failure (3), severe asthma (1), and others (1).   
All patients were placed on VV ECMO with Avalon cannula.  Early on, we experienced 
one incidence of cannula malposition into the right ventricle, which required surgical 
exploration. 8  Now with our routine use of fluoroscopy for cannulation, we have not experienced 
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any additional incidences of malposition of the cannula.  However, there have been 5 incidences 
of cannula migrations, which required reposition of the cannula under either fluoroscopy or 
ultrasound.9  No patient required conversion to the VA ECMO or extra-venous cannula in 
addition to the Avalon cannula system. 
The average length of VV ECMO was 11.5 ± 6.7 days.  Thirty four patients (76%) were 
successfully weaned from VV ECMO and survived of ECMO.  The details of 11 patients who 
died during VV ECMO were sepsis secondary to pre-existing infection (3), cardiac death related 
to implantable cardiac assist device (2), stroke (2),  non-recoverable pulmonary fibrosis (2), and 
ischemic bowel (2).  After ECMO decannulation, 29 patients (64%) were discharged home with 
appropriate neurological status.  
Conclusion 
Current practice of VV ECMO using a dual-lumen Avalon catheter requires experienced 
staff and adjunct equipment including ultrasound, echocardiography and fluoroscopy.  
Utilization of a standard protocol as described above will reduce complications and increase the 
likelihood of successful placement of VV ECMO.  
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Figure 1: Traditional VV ECMO circuit.  Double groin access, one cannula in the right atrium 
for inflow to the patient and another cannula in the inferior vena cava for outflow from the 
patient (Figure 1A).  Single groin access and upper extremity vein access, groin access for 
outflow and upper extremity for inflow (Figure 1B).  The issue of this traditional VV ECMO is 
recirculation and shunting of the blood from ECMO due to the proximity of the cannulas and 
possible low flow due to collapse of the vein used for outflow from the patient. 
Figure 2:  Current Avalon cannulation technique.  Guide wire placement to the inferior vena 
cava from right internal jugular vein (Figure 2A).  Sequential dilatation of the access site is done 
(Figure 2B).  The Avalon cannula is placed with distal port in the inferior vena cava and middle 
port facing to the tricuspid valve (Figure 2C). 
Figure 3:  Example of Avalon cannula position on chest x-ray (Figure 3A).  Echocardiography 
shows good flow toward the tricuspid valve (Figure 3B).  
